Page 4 - Christopherm Loftus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Christopherm loftus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Christopherm Loftus Today - Breaking & Trending Today

FDA authorizes marketing of a new device for use in patients undergoing stroke rehabilitation


FDA authorizes marketing of a new device for use in patients undergoing stroke rehabilitation
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation to facilitate muscle re-education and for maintaining or increasing range of motion. The Neurolutions IpsiHand Upper Extremity Rehabilitation System (IpsiHand System) is a Brain-Computer-Interface (BCI) device that assists in rehabilitation for stroke patients with upper extremity or hand, wrist and arm disability.
Thousands of stroke survivors require rehabilitation each year. Today s authorization offers certain chronic stroke patients undergoing stroke rehabilitation an additional treatment option to help them move their hands and arms again and fills an unmet need for patients who may not have access to home-based stroke rehabilitation technologies. ....

United States , Christopherm Loftus , Emily Henderson , Centers For Disease , Radiological Health , Office Of Neurological , Drug Administration , Ipsihand System , Acting Director , Physical Medicine Devices , Disease Control , Breakthrough Device , ஒன்றுபட்டது மாநிலங்களில் , எமிலி ஹென்டர்சன் , மையங்கள் க்கு நோய் , கதிரியக்கவியல் ஆரோக்கியம் , அலுவலகம் ஆஃப் நரம்பியல் , நடிப்பு இயக்குனர் , உடல் மருந்து சாதனங்கள் , நோய் கட்டுப்பாடு , திருப்புமுனை சாதனம் ,

FDA Clears the Q-Collar for Sale to Athletes in the US


Share this article
Share this article
WESTPORT, Conn., March 1, 2021 /PRNewswire/ Q30 Innovations is pleased to announce the FDA s recent authorization to market the Q-Collar in the United States. The FDA clearance is a major step forward in the company s mission to help better protect athletes from the effects of repeated head impacts.
The FDA s decision was based on a rigorous review of eight years of scientific research and clinical trials that demonstrate the safety and efficacy of the Q-Collar, including prospective, longitudinal studies in the United States with approximately 450 male and female athletes. The football study showed that over the course of a season of play, 77% of the collar wearing athletes had no significant changes in their deep brain tissues (white matter), compared to 73% of non-collar wearing participants who experienced significant changes. No adverse events have been associated with the use of the Q-Collar. ....

United States , Tom Hoey , Christopherm Loftus , Radiological Health , Office Of Neurological , Physical Medicine Devices , Q30 Innovations , ஒன்றுபட்டது மாநிலங்களில் , டோம் ஹோய் , கதிரியக்கவியல் ஆரோக்கியம் , அலுவலகம் ஆஃப் நரம்பியல் , உடல் மருந்து சாதனங்கள் ,